Nonoperating Income (Expense) in USD of aTYR PHARMA INC from 2015 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
aTYR PHARMA INC quarterly/annual Nonoperating Income (Expense) history and change rate from 2015 to Q3 2025.
  • aTYR PHARMA INC Nonoperating Income (Expense) for the quarter ending 30 Sep 2025 was $999,000.000, a 13.3% increase year-over-year.
  • aTYR PHARMA INC Nonoperating Income (Expense) for the twelve months ending 30 Sep 2025 was $3,524,000.000, a 16.8% decline year-over-year.
  • aTYR PHARMA INC annual Nonoperating Income (Expense) for 2024 was $3,892,000.000, a 13.9% decline from 2023.
  • aTYR PHARMA INC annual Nonoperating Income (Expense) for 2023 was $4,522,000.000, a 326% increase from 2022.
  • aTYR PHARMA INC annual Nonoperating Income (Expense) for 2022 was $1,061,000.000, a 346% increase from 2021.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Change (%)
Nonoperating Income (Expense), Annual (USD)
Nonoperating Income (Expense), YoY Annual Change (%)

aTYR PHARMA INC Quarterly Nonoperating Income (Expense) (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 $3,524,000 $999,000 +$117,000 +13.3% 01 Jul 2025 30 Sep 2025 10-Q 06 Nov 2025
Q2 2025 $3,407,000 $781,000 -$228,000 -22.6% 01 Apr 2025 30 Jun 2025 10-Q 07 Aug 2025
Q1 2025 $3,635,000 $892,000 -$257,000 -22.4% 01 Jan 2025 31 Mar 2025 10-Q 07 May 2025
Q4 2024 $3,892,000 $852,000 -$346,000 -28.9% 01 Oct 2024 31 Dec 2024 10-K 13 Mar 2025
Q3 2024 $4,238,000 $882,000 -$391,000 -30.7% 01 Jul 2024 30 Sep 2024 10-Q 06 Nov 2025
Q2 2024 $4,629,000 $1,009,000 -$207,000 -17% 01 Apr 2024 30 Jun 2024 10-Q 07 Aug 2025
Q1 2024 $4,836,000 $1,149,000 +$314,000 +37.6% 01 Jan 2024 31 Mar 2024 10-Q 07 May 2025
Q4 2023 $4,522,000 $1,198,000 +$771,000 +1.8% 01 Oct 2023 31 Dec 2023 10-K 13 Mar 2025
Q3 2023 $3,751,000 $1,273,000 +$1,026,000 +4.2% 01 Jul 2023 30 Sep 2023 10-Q 07 Nov 2024
Q2 2023 $2,725,000 $1,216,000 +$1,053,000 +6.5% 01 Apr 2023 30 Jun 2023 10-Q 13 Aug 2024
Q1 2023 $1,672,000 $835,000 +$611,000 +2.7% 01 Jan 2023 31 Mar 2023 10-Q 02 May 2024
Q4 2022 $1,061,000 $427,000 +$348,000 +4.4% 01 Oct 2022 31 Dec 2022 10-K 13 Mar 2025
Q3 2022 $713,000 $247,000 +$188,000 +3.2% 01 Jul 2022 30 Sep 2022 10-Q 09 Nov 2023
Q2 2022 $525,000 $163,000 +$110,000 +2.1% 01 Apr 2022 30 Jun 2022 10-Q 09 Aug 2023
Q1 2022 $415,000 $224,000 +$177,000 +3.8% 01 Jan 2022 31 Mar 2022 10-Q 09 May 2023
Q4 2021 $238,000 $79,000 +$74,000 +14.8% 01 Oct 2021 31 Dec 2021 10-K 14 Mar 2024
Q3 2021 $164,000 $59,000 +$147,000 01 Jul 2021 30 Sep 2021 10-Q 14 Nov 2022
Q2 2021 $17,000 $53,000 +$182,000 01 Apr 2021 30 Jun 2021 10-Q 15 Aug 2022
Q1 2021 -$165,000 $47,000 +$154,000 01 Jan 2021 31 Mar 2021 10-Q 10 May 2022
Q4 2020 -$319,000 $5,000 +$176,000 01 Oct 2020 31 Dec 2020 10-K 14 Mar 2023
Q3 2020 -$495,000 -$88,000 +$59,000 +40.1% 01 Jul 2020 30 Sep 2020 10-Q 12 Nov 2021
Q2 2020 -$554,000 -$129,000 +$78,000 +37.7% 01 Apr 2020 30 Jun 2020 10-Q 11 Aug 2021
Q1 2020 -$632,000 -$107,000 +$153,000 +58.8% 01 Jan 2020 31 Mar 2020 10-Q 14 May 2021
Q4 2019 -$785,000 -$171,000 +$188,000 +52.4% 01 Oct 2019 31 Dec 2019 10-K 15 Mar 2022
Q3 2019 -$973,000 -$147,000 +$290,000 +66.4% 01 Jul 2019 30 Sep 2019 10-Q 13 Nov 2020
Q2 2019 -$1,263,000 -$207,000 +$245,000 +54.2% 01 Apr 2019 30 Jun 2019 10-Q 13 Aug 2020
Q1 2019 -$1,508,000 -$260,000 +$187,000 +41.8% 01 Jan 2019 31 Mar 2019 10-Q 12 May 2020
Q4 2018 -$1,695,000 -$359,000 01 Oct 2018 31 Dec 2018 10-K 24 Mar 2021
Q3 2018 -$437,000 01 Jul 2018 30 Sep 2018 10-Q 14 Nov 2019
Q2 2018 -$452,000 01 Apr 2018 30 Jun 2018 10-Q 14 Aug 2019
Q1 2018 -$447,000 01 Jan 2018 31 Mar 2018 10-Q 14 May 2019

aTYR PHARMA INC Annual Nonoperating Income (Expense) (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $3,892,000 -$630,000 -13.9% 01 Jan 2024 31 Dec 2024 10-K 13 Mar 2025
2023 $4,522,000 +$3,461,000 +3.3% 01 Jan 2023 31 Dec 2023 10-K 13 Mar 2025
2022 $1,061,000 +$823,000 +3.5% 01 Jan 2022 31 Dec 2022 10-K 13 Mar 2025
2021 $238,000 +$557,000 01 Jan 2021 31 Dec 2021 10-K 14 Mar 2024
2020 -$319,000 +$466,000 +59.4% 01 Jan 2020 31 Dec 2020 10-K 14 Mar 2023
2019 -$785,000 +$910,000 +53.7% 01 Jan 2019 31 Dec 2019 10-K 15 Mar 2022
2018 -$1,695,000 -$633,000 -59.6% 01 Jan 2018 31 Dec 2018 10-K 24 Mar 2021
2017 -$1,062,000 -$1,098,000 -30.5% 01 Jan 2017 31 Dec 2017 10-K 26 Mar 2020
2016 $36,000 +$393,000 01 Jan 2016 31 Dec 2016 10-K 26 Mar 2019
2015 -$357,000 01 Jan 2015 31 Dec 2015 10-K 20 Mar 2018
* An asterisk sign (*) next to the value indicates that the value is likely invalid.